Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-25 @ 2:16 AM
NCT ID:
NCT00097760
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of MS as defined by McDonald et al., criteria # 1-4
* Between the ages of 18 and 55, inclusive
* Baseline EDSS score between 0.0 and 5.0, inclusive
* Have been treated with GA for at least the 12 months prior to randomization
Exclusion Criteria:
* Primary progressive, secondary progressive or progressive relapsing MS
* MS relapse has occurred within the 50 days prior to randomization
* A clinically significant infectious illness
* History of, or abnormal lab result indicative of significant disease that would preclude the administration of a recombinant humanized antibody immunomodulating agent or GA for 20 weeks.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT00097760
Study Brief:
Protocol Section:
NCT00097760